Discover the latest advancements in HIV prevention and how they offer hope for reducing infections, especially in the Black ...

Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in ...

While this type of drug, called pre-exposure prophylaxis (PrEP), has also been shown to be 99% effective in blocking HIV infections from sex in clinical trials, this is not necessarily the case in ...

Introduction Oral pre-exposure prophylaxis (PrEP) is a priority intervention for scale-up in countries with high HIV ...